Cannabis Stocks: Is Now The Time To Get Involved? Wall Street is aglow with the prospect of more and more cannabis companies trading shares on public markets. Investors have longed for the opportunity to put their money to work in companies that produce and sell cannabis and cannabis-related products. However, this has not been possible […]
Strainprint featured in The Herb Life – Chronic Pain Patients Rejoice: Relief May Come in the Form of Medical Cannabis Chronic pain is a multi-faceted condition with a variety of root causes and severity levels. Despite being such a complex topic, chronic pain has been typically treated the same way, with opioids. Medications like fentanyl, […]
Strainprint’s Director of Marketing and Communications, Jessica Moran, was featured on The Pivot podcast by CMO, talking about how crowd sourced cannabis data is redefining patient care. Have a listen below: About the CMO Lab Project To better understand the evolving role of the CMO and the emerging risks, challenges and opportunities facing marketers and […]
Strainprint’s CTO, David Berg, recently sat down with the Midas Letter Live to talk about our partnership with Cannabis At Work. About Midas Letter is the journal of “best-in-class” companies in all sectors. Publisher James West is a recognized authority on investing in the emerging company segment having been a regularly featured guest on Business […]
Learn more about Flavonoids in the Strainprint Community The cannabis herb produces more than 400 chemical compounds—all of which manifest in different efficacy profiles depending on consumption avenue, including ingestion (edibles) and inhalation (smoke and vapor, each producing different molecular profiles). The most noted and understood of these molecules are cannabinoids and terpenes. Cannabidiol (CBD) […]
Recent concerns demonstrate need to build on the positive foundation that exists.
Stephanie Karasick Featured on Business of Cannabis- talking Strainprint Community, expansion to new markets, and leading with kindness.